Perspectives: Direct and specific inhibition of factor Xa: an emerging therapeutic strategy for atherothrombotic disease

This article critically reviews the comparative mechanisms of action, the risks and benefits, together with the clinical evidence base for the use of these novel Xa inhibitors in the management of ACS patients.

Source: European Journal of Heart Failure Supplements - January 10, 2014 Category: Cardiology Authors: Santos-Gallego, C. G., Badimon, L., Badimon, J. J. Tags: Articles Source Type: research